{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T07:10:18Z","timestamp":1736406618651,"version":"3.32.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.micpath.2023.106170","type":"journal-article","created":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T15:35:32Z","timestamp":1685374532000},"page":"106170","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Role of host immunity and HBx among inactive chronic hepatitis B patients in a highly endemic region"],"prefix":"10.1016","volume":"181","author":[{"given":"Nafise","family":"Yousefpoor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malihe","family":"Mahdavian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zohre","family":"Pourbagher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanaz","family":"Ahmadi Ghezeldasht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arman","family":"Mosavat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masood","family":"Ziaee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masoumeh","family":"Bahreini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saman","family":"Soleimanpour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Reza","family":"Sharifmoghadam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narges","family":"Valizadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arghvan","family":"Asghari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alijan","family":"Tabarraie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6814-5992","authenticated-orcid":false,"given":"Seyed Abdolrahim","family":"Rezaee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.micpath.2023.106170_bib1","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1053\/j.gastro.2018.10.048","article-title":"What is needed to eliminate hepatitis B virus and hepatitis C virus as global health threats","volume":"156","author":"Ward","year":"2019","journal-title":"Gastroenterology"},{"year":"2017","series-title":"Global Hepatitis Report 2017","author":"Organization","key":"10.1016\/j.micpath.2023.106170_bib2"},{"issue":"2","key":"10.1016\/j.micpath.2023.106170_bib3","first-page":"91","article-title":"Prevalence of hepatitis B virus infection among Iranian high risk groups: a systematic review and meta-analysis","volume":"11","author":"Almasi-Hashiani","year":"2018","journal-title":"Gastroenterol. Hepatol. Bed Bench"},{"key":"10.1016\/j.micpath.2023.106170_bib4","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.meegid.2018.02.004","article-title":"Genotype characteristic and phylogenetic analysis of hepatitis B virus in northeast-Iran","volume":"59","author":"Nodeh","year":"2018","journal-title":"Infect. Genet. Evol."},{"issue":"4","key":"10.1016\/j.micpath.2023.106170_bib5","first-page":"403","article-title":"The changing epidemiology of viral hepatitis B in Iran","volume":"16","author":"Alavian","year":"2007","journal-title":"J. Gastrointestin. Liver Dis."},{"issue":"8","key":"10.1016\/j.micpath.2023.106170_bib6","doi-asserted-by":"crossref","first-page":"8","DOI":"10.5812\/hepatmon.65473","article-title":"High prevalence of hepatitis B virus infection in the village of Esfandiar in South Khorasan province, Iran","volume":"18","author":"Javanmard","year":"2018","journal-title":"Hepat. Mon."},{"issue":"1","key":"10.1016\/j.micpath.2023.106170_bib7","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/epirev\/mxj009","article-title":"Hepatitis B virus infection: epidemiology and vaccination","volume":"28","author":"Shepard","year":"2006","journal-title":"Epidemiol. Rev."},{"year":"2015","series-title":"WHO Guidelines Approved by the Guidelines Review Committee. Guidelines for the Prevention, Care and Treatment of Persons with Chronic Hepatitis B Infection","key":"10.1016\/j.micpath.2023.106170_bib8"},{"issue":"9","key":"10.1016\/j.micpath.2023.106170_bib9","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S2468-1253(22)00124-8","article-title":"Global, regional, and national burden of hepatitis B, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"7","year":"2022","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.micpath.2023.106170_bib10","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.cld.2007.08.001","article-title":"The immunology of hepatitis B","volume":"11","author":"Vierling","year":"2007","journal-title":"Clin. Liver Dis."},{"issue":"23","key":"10.1016\/j.micpath.2023.106170_bib11","doi-asserted-by":"crossref","first-page":"12725","DOI":"10.1128\/JVI.78.23.12725-12734.2004","article-title":"The enigmatic X gene of hepatitis B virus","volume":"78","author":"Bouchard","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.micpath.2023.106170_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2021.105136","article-title":"C-terminal-truncated hepatitis B virus X protein promotes hepatocarcinogenesis by activating the MAPK pathway","volume":"159","author":"Zhang","year":"2021","journal-title":"Microb. Pathog."},{"issue":"39","key":"10.1016\/j.micpath.2023.106170_bib13","doi-asserted-by":"crossref","first-page":"4932","DOI":"10.3748\/wjg.v16.i39.4932","article-title":"HBx-induced reactive oxygen species activates hepatocellular carcinogenesis via dysregulation of PTEN\/Akt pathway","volume":"16","author":"Ha","year":"2010","journal-title":"World J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.micpath.2023.106170_bib14","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3390\/v12030285","article-title":"The interactions between HBV and the innate immunity of hepatocytes","volume":"12","author":"Megahed","year":"2020","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.micpath.2023.106170_bib15","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s12016-014-8465-4","article-title":"Cytokine-mediated immunopathogenesis of hepatitis B virus infections","volume":"50","author":"Li","year":"2016","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"1","key":"10.1016\/j.micpath.2023.106170_bib16","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1189\/jlb.1208761","article-title":"Interferon\u2010\u03bbs: the modulators of antivirus, antitumor, and immune responses","volume":"86","author":"Li","year":"2009","journal-title":"J. Leukoc. Biol."},{"issue":"3","key":"10.1016\/j.micpath.2023.106170_bib17","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3390\/vaccines4030023","article-title":"Viral inhibition of the IFN-induced JAK\/STAT signalling pathway: development of live attenuated vaccines by mutation of viral-encoded IFN-antagonists","volume":"4","author":"Fleming","year":"2016","journal-title":"Vaccines (Basel)"},{"issue":"2","key":"10.1016\/j.micpath.2023.106170_bib18","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/COH.0b013e328335c0c1","article-title":"Th17 and regulatory T cells: implications for AIDS pathogenesis","volume":"5","author":"Kanwar","year":"2010","journal-title":"Curr. Opin. HIV AIDS"},{"author":"Liang","key":"10.1016\/j.micpath.2023.106170_bib19"},{"issue":"1","key":"10.1016\/j.micpath.2023.106170_bib20","doi-asserted-by":"crossref","first-page":"7","DOI":"10.7150\/ijms.8352","article-title":"The expression levels of transcription factors T-bet, GATA-3, ROR\u03b3t and FOXP3 in peripheral blood lymphocyte (PBL) of patients with liver cancer and their significance","volume":"12","author":"Lin","year":"2015","journal-title":"Int. J. Med. Sci."},{"issue":"7","key":"10.1016\/j.micpath.2023.106170_bib21","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/ni.2059","article-title":"T-bet in disease","volume":"12","author":"Lazarevic","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.micpath.2023.106170_bib22","doi-asserted-by":"crossref","unstructured":"Lin N, Yin W, Miller H, Byazrova MG, Herrada AA, Benlagha K, et al. The role of regulatory T cells and follicular T helper cells in HBV infection. Front. Immunol..14:2242..","DOI":"10.3389\/fimmu.2023.1169601"},{"issue":"7","key":"10.1016\/j.micpath.2023.106170_bib23","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/ni.2046","article-title":"Transcription factor T-bet represses expression of the inhibitory receptor PD-1 and sustains virus-specific CD8+ T cell responses during chronic infection","volume":"12","author":"Kao","year":"2011","journal-title":"Nat. Immunol."},{"issue":"16","key":"10.1016\/j.micpath.2023.106170_bib24","doi-asserted-by":"crossref","DOI":"10.15252\/embj.201899013","article-title":"A temporally dynamic Foxp3 autoregulatory transcriptional circuit controls the effector Treg programme","volume":"37","author":"Bending","year":"2018","journal-title":"EMBO J."},{"issue":"6","key":"10.1016\/j.micpath.2023.106170_bib25","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1200\/JCO.2009.25.3641","article-title":"The PI3K pathway as drug target in human cancer","volume":"28","author":"Courtney","year":"2010","journal-title":"J. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.micpath.2023.106170_bib26","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/nrc2664","article-title":"Targeting PI3K signalling in cancer: opportunities, challenges and limitations","volume":"9","author":"Engelman","year":"2009","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.micpath.2023.106170_bib27","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1128\/JVI.02440-14","article-title":"The hepatitis B virus (HBV) HBx protein activates AKT to simultaneously regulate HBV replication and hepatocyte survival","volume":"89","author":"Rawat","year":"2015","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.micpath.2023.106170_bib28","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/hep.29800","article-title":"Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance","volume":"67","author":"Terrault","year":"2018","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.micpath.2023.106170_bib29","first-page":"1324","article-title":"Game theory applications in host-microbe interactions toward disease manifestation: Mycobacterium tuberculosis infection as an example","volume":"24","author":"Sharebiani","year":"2021","journal-title":"Iran J. Basic Med. Sci."},{"issue":"2","key":"10.1016\/j.micpath.2023.106170_bib30","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.antiviral.2003.08.012","article-title":"Role of hepatitis B virus specific cytotoxic T cells in liver damage and viral control","volume":"60","author":"Bertoletti","year":"2003","journal-title":"Antivir. Res."},{"issue":"1","key":"10.1016\/j.micpath.2023.106170_bib31","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jhep.2009.10.016","article-title":"Immune-mediated liver injury","volume":"52","author":"Lohse","year":"2010","journal-title":"J. Hepatol."},{"key":"10.1016\/j.micpath.2023.106170_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.107331","article-title":"The role of Th17 cells in viral infections","volume":"91","author":"Aghbash","year":"2021","journal-title":"Int. Immunopharm."},{"issue":"2","key":"10.1016\/j.micpath.2023.106170_bib33","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"67","year":"2017","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.micpath.2023.106170_bib34","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12865-019-0309-9","article-title":"CD4(+) T cell exhaustion revealed by high PD-1 and LAG-3 expression and the loss of helper T cell function in chronic hepatitis B","volume":"20","author":"Dong","year":"2019","journal-title":"BMC Immunol."},{"issue":"2","key":"10.1016\/j.micpath.2023.106170_bib35","first-page":"67","article-title":"Regulatory T-cells promote hepatitis B virus infection and hepatocellular carcinoma progression","volume":"2","author":"Li","year":"2016","journal-title":"Chronic Dis. Transl. Med."},{"issue":"11","key":"10.1016\/j.micpath.2023.106170_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013869","article-title":"Decreased ratio of Treg cells to Th17 cells correlates with HBV DNA suppression in chronic hepatitis B patients undergoing entecavir treatment","volume":"5","author":"Zhang","year":"2010","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.micpath.2023.106170_bib37","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1128\/JVI.76.7.3570-3574.2002","article-title":"Inhibition of hepatitis B virus replication by interferon requires proteasome activity","volume":"76","author":"Robek","year":"2002","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.micpath.2023.106170_bib38","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3349\/ymj.2015.56.3.625","article-title":"IL28B is associated with outcomes of chronic HBV infection","volume":"56","author":"Shi","year":"2015","journal-title":"Yonsei Med. J."},{"issue":"11","key":"10.1016\/j.micpath.2023.106170_bib39","doi-asserted-by":"crossref","first-page":"6413","DOI":"10.4049\/jimmunol.1001829","article-title":"The role of the transcription factor CREB in immune function","volume":"185","author":"Wen","year":"2010","journal-title":"J. Immunol."}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401023002036?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401023002036?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T06:33:42Z","timestamp":1736404422000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401023002036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":39,"alternative-id":["S0882401023002036"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2023.106170","relation":{},"ISSN":["0882-4010"],"issn-type":[{"type":"print","value":"0882-4010"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of host immunity and HBx among inactive chronic hepatitis B patients in a highly endemic region","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2023.106170","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106170"}}